Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bempedoic acid vs placebo in hyper-LDL cholesterolemia (Japan, statin inadequate/intolerant)
jRCT2031220562Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypercholesterolemia comparing Bempedoic acid 180 mg with Placebo (2 arms). Primary endpoint: Percent change in LDL-C from baseline at Week 12. Started Feb 2023; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2031220562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220562.